S100A8 and chronic obstructive pulmonary disease: The predominant role of S100A8/9-mediated RAGE activation in COPD is evident from the observation that lower levels of S100A8/9 in RAGE-deficient mice result in decreased cigarette smoke-induced inflammation (58).